Yichen W. Tong
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates.
Journal: Journal of medicinal chemistry
Published: February 15, 2024
Discovery of the First Potent DYRK2 Proteolysis Targeting Chimera Degraders.
Journal: ACS medicinal chemistry letters
Published: February 04, 2024
Targeting EGFR degradation by autophagosome degraders.
Journal: European journal of medicinal chemistry
Published: January 27, 2024
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides.
Journal: Journal of medicinal chemistry
Published: August 31, 2023
Discovery of Small-Molecule Degraders for Alpha-Synuclein Aggregates.
Journal: Journal of medicinal chemistry
Published: June 02, 2023
Xyloketal B Reverses Nutritional Hepatic Steatosis, Steatohepatitis, and Liver Fibrosis through Activation of the PPARα/PGC1α Signaling Pathway.
Journal: Journal of natural products
Published: June 24, 2022
Marine-Derived Xyloketal Compound Ameliorates MPP+-Induced Neuronal Injury through Regulating of the IRE1/XBP1 Signaling Pathway.
Journal: ACS chemical neuroscience
Published: August 02, 2021
Automatic Prediction of MGMT Status in Glioblastoma via Deep Learning-Based MR Image Analysis.
Journal: BioMed research international
Published: June 16, 2020
Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology.
Journal: Current medicinal chemistry
Published: November 25, 2019
Studies on the Design and Synthesis of Marine Peptide Analogues and Their Ability to Promote Proliferation in HUVECs and Zebrafish.
Journal: Molecules (Basel, Switzerland)
Published: November 30, 2018
Delivery of therapeutics and molecules using self-assembled peptides.
Journal: Current medicinal chemistry
Published: February 06, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026